Experiment 449688

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED

Compounds isolated

SOYASAPOGENOL B,3-O-(ALPHA-L-RHAMNOSYL-(1-2)-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL):

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
KIDNEY STONE DEVELOPMENT INHIBITION
Administration routeINTRAGASTRIC
OrganismDesmodium styracifolium (FABACEAE)
CitationKUBO,T: KAJIMOTO,T: NOHARA,T: HIRAYAMA,H: IKEGAMI,K: IRINO,N:. (1989). ISOLATION OF TRITERPENOIDAL SAPONINS AS ACTIVE INGREDIENTS IN PREVENTING KIDNEY STONES.. ()
Amount utilized
Compound isolated
DiseaseCOMPOUND GIVEN DAILY INCREASED URINARY CITRIC ACID AND CREATININE.
Dose amount0.6 MCG
Number2
Qualitative resultACTIVE
AnimalRAT
Per unitKG
Dose expressionDOSE